Caption Management’s Sarepta Therapeutics SRPT Stock Holding History

Caption Management’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$179K	Sell	9,957 -47,933	-83%	-$907K	﹤0.01%	1476
2026 Q1	$1.26M	Buy	57,890 +17,000	+42%	+$329K	0.01%	947
2025 Q4	$880K	Buy	40,890 +5,357	+15%	+$113K	0.01%	1103
2025 Q3	$685K	Buy	+35,533	New	+$633K	0.01%	1223
2025 Q2	–	Sell	-7,000	Closed	-$299K	–	1864
2025 Q1	$447K	Sell	7,000 -16,000	-70%	-$1.68M	﹤0.01%	1123
2024 Q4	$2.8M	Sell	23,000 -5,071	-18%	-$621K	0.03%	577
2024 Q3	$3.51M	Sell	28,071 -198,929	-88%	-$27.5M	0.06%	388
2024 Q2	$35.9M	Buy	227,000 +76,654	+51%	+$9.85M	0.55%	39
2024 Q1	$19.5M	Buy	150,346 +150,046	+50,015%	+$18.4M	0.3%	72
2023 Q4	$28.9K	Buy	+300	New	+$28.8K	﹤0.01%	1245
2023 Q2	–	Sell	-2,079	Closed	-$268K	–	1387
2023 Q1	$287K	Buy	+2,079	New	+$270K	0.01%	884
2022 Q4	–	Sell	-772	Closed	-$89.5K	–	1685
2022 Q3	$84K	Buy	+772	New	+$77.8K	﹤0.01%	1346
2020 Q1	–	Sell	-21,000	Closed	-$2.4M	–	1061
2019 Q4	$2.71M	Buy	+21,000	New	+$2.12M	0.09%	301
2019 Q2	–	Sell	-13,100	Closed	-$1.59M	–	813
2019 Q1	$1.56M	Buy	+13,100	New	+$1.68M	0.09%	280

Other funds holding SRPT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Caption Management's SRPT Position: Q2 2026 in Review

Caption Management reduced its Sarepta Therapeutics (SRPT) stake by 83% in Q2 2026, selling an estimated $907K and leaving 9,957 shares worth $179K. The position accounts for ﹤0.01% of the portfolio, ranked #1476.

Caption Management first reported a position in SRPT in Q1 2019 and has held it in 14 quarters since. The position peaked at $35.9M in Q2 2024. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

Caption Management held 9,957 shares of Sarepta Therapeutics worth $179K as of Q2 2026.
Caption Management sold 47,933 Sarepta Therapeutics shares in Q2 2026, an estimated $907K.
Sarepta Therapeutics made up ﹤0.01% of Caption Management's portfolio in Q2 2026, its #1476 holding.
Caption Management first reported a position in Sarepta Therapeutics in Q1 2019 and has held it in 14 quarters since.
Caption Management's Sarepta Therapeutics position peaked at $35.9M in Q2 2024.
323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.